Influenza Diagnostics Market Developments by 2031
MARKET OVERVIEW
Influenza diagnostics comprises of a number of flu tests that are used to detect influenza viruses in respiratory specimens. The most common are called "rapid influenza diagnostic tests." The rapid influenza diagnostic tests work by detecting the parts of the virus (antigens) that stimulate an immune response.
MARKET SCOPE
The "Global Influenza Diagnostics Market Analysis to 2031" is a specialized and in-depth study of the medical device industry with a special focus on the global market trend analysis. The report aims to provide an overview of the influenza diagnostics market with detailed market segmentation by type, end user and geography. The report provides key statistics on the market status of the leading influenza diagnostics market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
- Based on type, the global influenza diagnostics market is segmented into molecular diagnostic tests, traditional diagnostic tests.
- On the basis of end user, the market is segmented into reference laboratories, hospitals/clinical laboratories and other end users.
MARKET DYNAMICS
Drivers
- Increasing prevalence and incidence of influenza.
- Rising demand for faster diagnostic test for influenza.
- Increasing number of patients acquiring infections.
Restraints
- Variability in test sensitivity and specificity.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The influenza diagnostics market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the influenza diagnostics market in these regions.
IMPACT OF COVID-19 ON INFLUENZA DIAGNOSTICS MARKET
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The global outbreak of COVID-19 has impacted all the industries.
The rising burden of infectious diseases across the globe has increased the demand for infectious disease diagnosis products, including influenza & other diseases. The recent outbreak of the coronavirus disease (COVID-19), which has emerged since December 2019 in Wuhan, China, has caused destruction in several countries across the world. According to the WHO, as of 1st June 2021, there were 6,057,853 confirmed cases and 371,166 confirmed deaths. During this pandemic, it is important to minimize the spread of the disease by early diagnosis.
When compared to influenza with COVID-19, both viruses have a similar disease presentation i.e. they both cause respiratory issues. Moreover, both are transmitted by contact, droplets, and fomites. At earlier stages, COVID-19 patients are misdiagnosed with influenza and due to which its demand has raised in late 2021. However, soon it was realized that factors such as immunity, age group, transmission rate, vaccination, & few others are drastically different in case of COVID-19 & influenza. Thus, after realizing the difference between these two infections, the demand for influenza kits was normalized and the need for a comprehensive approach for diagnosis & treatment has gained importance to combat COVID-19 pandemic.
Mrinal Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any. 
Have a question?
Speak to Analyst
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The influenza diagnostics market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the influenza diagnostics market in these regions.
IMPACT OF COVID-19 ON INFLUENZA DIAGNOSTICS MARKET
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The global outbreak of COVID-19 has impacted all the industries.
The rising burden of infectious diseases across the globe has increased the demand for infectious disease diagnosis products, including influenza & other diseases. The recent outbreak of the coronavirus disease (COVID-19), which has emerged since December 2019 in Wuhan, China, has caused destruction in several countries across the world. According to the WHO, as of 1st June 2021, there were 6,057,853 confirmed cases and 371,166 confirmed deaths. During this pandemic, it is important to minimize the spread of the disease by early diagnosis.
When compared to influenza with COVID-19, both viruses have a similar disease presentation i.e. they both cause respiratory issues. Moreover, both are transmitted by contact, droplets, and fomites. At earlier stages, COVID-19 patients are misdiagnosed with influenza and due to which its demand has raised in late 2021. However, soon it was realized that factors such as immunity, age group, transmission rate, vaccination, & few others are drastically different in case of COVID-19 & influenza. Thus, after realizing the difference between these two infections, the demand for influenza kits was normalized and the need for a comprehensive approach for diagnosis & treatment has gained importance to combat COVID-19 pandemic.
MARKET PLAYERS
The report covers key developments in the influenza diagnostics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from influenza diagnostics market are anticipated to lucrative growth opportunities in the future with the rising demand for influenza diagnostics in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the influenza diagnostics market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
- Abbott
- Quidel Corporation
- BioMérieux
- BD
- F. Hoffmann-La Roche Ltd
- Oxford Biosystems
- Thermo Fisher Scientific
- Meridian Bioscience
- Cepheid
- altona Diagnostics GmbH
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Influenza Diagnostics Market - By Type
1.3.2 Influenza Diagnostics Market - By End User
1.3.3 Influenza Diagnostics Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. INFLUENZA DIAGNOSTICS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. INFLUENZA DIAGNOSTICS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. INFLUENZA DIAGNOSTICS MARKET - GLOBAL MARKET ANALYSIS
6.1. INFLUENZA DIAGNOSTICS - GLOBAL MARKET OVERVIEW
6.2. INFLUENZA DIAGNOSTICS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. INFLUENZA DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. MOLECULAR DIAGNOSTIC TESTS
7.3.1. Overview
7.3.2. Molecular Diagnostic Tests Market Forecast and Analysis
7.3.3. RT-PCR Market
7.3.3.1. Overview
7.3.3.2. RT-PCR Market Forecast and Analysis
7.3.4. Loop-Mediated Isothermal Amplification-Based Assays Market
7.3.4.1. Overview
7.3.4.2. Loop-Mediated Isothermal Amplification-Based Assays Market Forecast and Analysis
7.3.5. Nucleic Acid Sequence-Based Amplification Market
7.3.5.1. Overview
7.3.5.2. Nucleic Acid Sequence-Based Amplification Market Forecast and Analysis
7.3.6. Simple Amplification-Based Assays Market
7.3.6.1. Overview
7.3.6.2. Simple Amplification-Based Assays Market Forecast and Analysis
7.3.7. Other Molecular Diagnostic Tests Market
7.3.7.1. Overview
7.3.7.2. Other Molecular Diagnostic Tests Market Forecast and Analysis
7.4. TRADITIONAL DIAGNOSTIC TESTS
7.4.1. Overview
7.4.2. Traditional Diagnostic Tests Market Forecast and Analysis
7.4.3. Viral Culture Market
7.4.3.1. Overview
7.4.3.2. Viral Culture Market Forecast and Analysis
7.4.4. Serological Assays Market
7.4.4.1. Overview
7.4.4.2. Serological Assays Market Forecast and Analysis
7.4.5. Rapid Influenza Detection Market
7.4.5.1. Overview
7.4.5.2. Rapid Influenza Detection Market Forecast and Analysis
7.4.6. Direct Fluorescent Antibody Market
7.4.6.1. Overview
7.4.6.2. Direct Fluorescent Antibody Market Forecast and Analysis
8. INFLUENZA DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2028 - END USER
8.1. OVERVIEW
8.2. END USER MARKET FORECASTS AND ANALYSIS
8.3. REFERENCE LABORATORIES
8.3.1. Overview
8.3.2. Reference Laboratories Market Forecast and Analysis
8.4. HOSPITALS/CLINICAL LABORATORIES
8.4.1. Overview
8.4.2. Hospitals/Clinical Laboratories Market Forecast and Analysis
8.5. OTHER END USERS
8.5.1. Overview
8.5.2. Other End Users Market Forecast and Analysis
9. INFLUENZA DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Influenza Diagnostics Market Overview
9.1.2 North America Influenza Diagnostics Market Forecasts and Analysis
9.1.3 North America Influenza Diagnostics Market Forecasts and Analysis - By Type
9.1.4 North America Influenza Diagnostics Market Forecasts and Analysis - By End User
9.1.5 North America Influenza Diagnostics Market Forecasts and Analysis - By Countries
9.1.5.1 United States Influenza Diagnostics Market
9.1.5.1.1 United States Influenza Diagnostics Market by Type
9.1.5.1.2 United States Influenza Diagnostics Market by End User
9.1.5.2 Canada Influenza Diagnostics Market
9.1.5.2.1 Canada Influenza Diagnostics Market by Type
9.1.5.2.2 Canada Influenza Diagnostics Market by End User
9.1.5.3 Mexico Influenza Diagnostics Market
9.1.5.3.1 Mexico Influenza Diagnostics Market by Type
9.1.5.3.2 Mexico Influenza Diagnostics Market by End User
9.2. EUROPE
9.2.1 Europe Influenza Diagnostics Market Overview
9.2.2 Europe Influenza Diagnostics Market Forecasts and Analysis
9.2.3 Europe Influenza Diagnostics Market Forecasts and Analysis - By Type
9.2.4 Europe Influenza Diagnostics Market Forecasts and Analysis - By End User
9.2.5 Europe Influenza Diagnostics Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Influenza Diagnostics Market
9.2.5.1.1 Germany Influenza Diagnostics Market by Type
9.2.5.1.2 Germany Influenza Diagnostics Market by End User
9.2.5.2 France Influenza Diagnostics Market
9.2.5.2.1 France Influenza Diagnostics Market by Type
9.2.5.2.2 France Influenza Diagnostics Market by End User
9.2.5.3 Italy Influenza Diagnostics Market
9.2.5.3.1 Italy Influenza Diagnostics Market by Type
9.2.5.3.2 Italy Influenza Diagnostics Market by End User
9.2.5.4 Spain Influenza Diagnostics Market
9.2.5.4.1 Spain Influenza Diagnostics Market by Type
9.2.5.4.2 Spain Influenza Diagnostics Market by End User
9.2.5.5 United Kingdom Influenza Diagnostics Market
9.2.5.5.1 United Kingdom Influenza Diagnostics Market by Type
9.2.5.5.2 United Kingdom Influenza Diagnostics Market by End User
9.2.5.6 Rest of Europe Influenza Diagnostics Market
9.2.5.6.1 Rest of Europe Influenza Diagnostics Market by Type
9.2.5.6.2 Rest of Europe Influenza Diagnostics Market by End User
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Influenza Diagnostics Market Overview
9.3.2 Asia-Pacific Influenza Diagnostics Market Forecasts and Analysis
9.3.3 Asia-Pacific Influenza Diagnostics Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Influenza Diagnostics Market Forecasts and Analysis - By End User
9.3.5 Asia-Pacific Influenza Diagnostics Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Influenza Diagnostics Market
9.3.5.1.1 Australia Influenza Diagnostics Market by Type
9.3.5.1.2 Australia Influenza Diagnostics Market by End User
9.3.5.2 China Influenza Diagnostics Market
9.3.5.2.1 China Influenza Diagnostics Market by Type
9.3.5.2.2 China Influenza Diagnostics Market by End User
9.3.5.3 India Influenza Diagnostics Market
9.3.5.3.1 India Influenza Diagnostics Market by Type
9.3.5.3.2 India Influenza Diagnostics Market by End User
9.3.5.4 Japan Influenza Diagnostics Market
9.3.5.4.1 Japan Influenza Diagnostics Market by Type
9.3.5.4.2 Japan Influenza Diagnostics Market by End User
9.3.5.5 South Korea Influenza Diagnostics Market
9.3.5.5.1 South Korea Influenza Diagnostics Market by Type
9.3.5.5.2 South Korea Influenza Diagnostics Market by End User
9.3.5.6 Rest of Asia-Pacific Influenza Diagnostics Market
9.3.5.6.1 Rest of Asia-Pacific Influenza Diagnostics Market by Type
9.3.5.6.2 Rest of Asia-Pacific Influenza Diagnostics Market by End User
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Influenza Diagnostics Market Overview
9.4.2 Middle East and Africa Influenza Diagnostics Market Forecasts and Analysis
9.4.3 Middle East and Africa Influenza Diagnostics Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Influenza Diagnostics Market Forecasts and Analysis - By End User
9.4.5 Middle East and Africa Influenza Diagnostics Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Influenza Diagnostics Market
9.4.5.1.1 South Africa Influenza Diagnostics Market by Type
9.4.5.1.2 South Africa Influenza Diagnostics Market by End User
9.4.5.2 Saudi Arabia Influenza Diagnostics Market
9.4.5.2.1 Saudi Arabia Influenza Diagnostics Market by Type
9.4.5.2.2 Saudi Arabia Influenza Diagnostics Market by End User
9.4.5.3 U.A.E Influenza Diagnostics Market
9.4.5.3.1 U.A.E Influenza Diagnostics Market by Type
9.4.5.3.2 U.A.E Influenza Diagnostics Market by End User
9.4.5.4 Rest of Middle East and Africa Influenza Diagnostics Market
9.4.5.4.1 Rest of Middle East and Africa Influenza Diagnostics Market by Type
9.4.5.4.2 Rest of Middle East and Africa Influenza Diagnostics Market by End User
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Influenza Diagnostics Market Overview
9.5.2 South and Central America Influenza Diagnostics Market Forecasts and Analysis
9.5.3 South and Central America Influenza Diagnostics Market Forecasts and Analysis - By Type
9.5.4 South and Central America Influenza Diagnostics Market Forecasts and Analysis - By End User
9.5.5 South and Central America Influenza Diagnostics Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Influenza Diagnostics Market
9.5.5.1.1 Brazil Influenza Diagnostics Market by Type
9.5.5.1.2 Brazil Influenza Diagnostics Market by End User
9.5.5.2 Argentina Influenza Diagnostics Market
9.5.5.2.1 Argentina Influenza Diagnostics Market by Type
9.5.5.2.2 Argentina Influenza Diagnostics Market by End User
9.5.5.3 Rest of South and Central America Influenza Diagnostics Market
9.5.5.3.1 Rest of South and Central America Influenza Diagnostics Market by Type
9.5.5.3.2 Rest of South and Central America Influenza Diagnostics Market by End User
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL INFLUENZA DIAGNOSTICS MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. INFLUENZA DIAGNOSTICS MARKET, KEY COMPANY PROFILES
12.1. ABBOTT
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. QUIDEL CORPORATION
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. F. HOFFMANN-LA ROCHE LTD
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. BIOMéRIEUX
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. BD
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. OXFORD BIOSYSTEMS
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. THERMO FISHER SCIENTIFIC
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. MERIDIAN BIOSCIENCE
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. CEPHEID
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. ALTONA DIAGNOSTICS GMBH
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies
1. Abbott
2. Quidel Corporation
3. BioMérieux
4. BD
5. F. Hoffmann-La Roche Ltd
6. Oxford Biosystems
7. Thermo Fisher Scientific
8. Meridian Bioscience
9. Cepheid
10. altona Diagnostics GmbH
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For